COMPANY

Laplace Interventional

HQ: Plymouth, MN source · laplaceint.com ↗

Location: Plymouth, MN · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Tricuspid Regurgitation Severe Tricuspid Valve Regurgitation Tricuspid Valve Regurgitation Tricuspid Valve Disease Cardiovascular Diseases Heart Valve Diseases Tricuspid Valve Insufficiency Severe Heart Valve Disease Symptomatic Tricuspid Regurgitation Laplace TTVR System

3Trials (company is sponsor)

Timeline

2026-09 Trial start Not phased (device or behavioral study): Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System source ↗
Jun 18, 2024 Trial start Not phased (device or behavioral study): Laplace Early Feasibility Study - Canada source ↗
Feb 19, 2024 Trial start Not phased (device or behavioral study): Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System source ↗

Upcoming milestones

2027-12 (ESTIMATED) · Not phased · Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System · NCT06183684
Dec 30, 2027 (ESTIMATED) · Not phased · Laplace Early Feasibility Study - Canada · NCT07171060
2029-09 (ESTIMATED) · Not phased · Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System · NCT07687485

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT06183684	Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System	Not phased (device or behavioral study)	Recruiting	Feb 19, 2024	2027-12 (estimated)
NCT07171060	Laplace Early Feasibility Study - Canada	Not phased (device or behavioral study)	Recruiting	Jun 18, 2024	Dec 30, 2027 (estimated)
NCT07687485	Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System	Not phased (device or behavioral study)	Not yet recruiting	2026-09	2029-09 (estimated)